AIP.NASDAQArteris, INC

Form 4: Arteris Inc. VP and General Counsel Paul Alpern Reports Stock Sales and Option Exercises

Sentiment:

SEC Form 4 Filing


Paul Alpern, VP and General Counsel of Arteris, Inc., reports multiple transactions involving the sale of common stock and the exercise of stock options, pursuant to a pre-arranged 10b5-1 trading plan.

Summary

  • On June 3, 2024, Paul Alpern, VP and General Counsel of Arteris, Inc., executed several transactions involving the company's common stock.
  • These transactions included the sale of 10,000 shares at an average price of $7.8571, the exercise of options for 1,250 shares at $0.60, and the subsequent sale of those 1,250 shares at an average price of $7.8574.
  • Additionally, Alpern exercised options for 10,000 shares at $0.56.
  • On June 4, 2024, Alpern sold 258 shares at $7.8125 and 424 shares at an average price of $7.6298.
  • These transactions were made pursuant to a 10b5-1 trading plan adopted on August 16, 2023.
  • Following these transactions, Alpern beneficially owns 80,360 restricted stock units and a total of 80,784 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports routine transactions under a pre-arranged trading plan. There is no indication of positive or negative sentiment towards the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders. It provides transparency into the trading activities of company executives and their potential impact on the stock's price and investor sentiment.

Stakeholder Impact

  • The stock sales could have a minor negative impact on shareholder sentiment if investors interpret it as a lack of confidence by the executive, although the 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
08/26/202025% of the total shares vested.
09/26/20201/48th of the total shares have vested monthly for 3 years, beginning on this date.
07/23/202125% of the total shares vested.
08/23/20211/48th of the total shares vest monthly for 3 years, beginning on this date.
08/16/2023Date the 10b5-1 trading plan was adopted.
06/03/2024Date of multiple stock sales and option exercises.
06/04/2024Date of additional stock sales.
06/05/2024Date of signature on the Form 4.
07/22/2030Expiration date of some stock options.
10/23/2029Expiration date of some stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.